Olmecip 20mg
| SKU | 758 |
|---|---|
| Generic For | Benicar |
| Strength | 20mg |
| Active Ingredient | Olmesartan |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.58 | US$ 17.5036%US$ 27.50 | |||
|
|||||
| 60 Tablet/s | US$ 0.54 | US$ 32.5041%US$ 55.00 | |||
|
|||||
| 100 Tablet/s | US$ 0.48 | US$ 47.5048%US$ 91.66 | |||
|
|||||
Olmecip 20 mg is a prescription medicine mainly used for treating and managing high blood pressure (hypertension) in adults. It may be prescribed in some cases of heart failure or for kidney protection in people with type 2 diabetes who also suffer from high blood pressure. The active ingredient of the medicine is Olmesartan, which belongs to a group of drugs called angiotensin II receptor blockers (ARBs). This group of drugs works by blocking the effects of angiotensin II, a hormone that constricts the blood vessels and raises blood pressure. The medicine prevents this hormone from binding to its receptors, thereby causing the widening of blood vessels and ultimately leading to a decrease in blood pressure. Thus, Olmecip prevents strokes, heart attacks, and kidney problems, making it an important and effective medication in the prevention of cardiovascular disease. Cipla Ltd. manufactures this medicine. The major benefits of Olmesartan are that it works by blocking only angiotensin II receptors, without affecting other receptors in the body. This targeted approach makes the drug very effective and presents high tolerability in most patients.
Mechanism of action: When Olmecip is ingested, it is converted into its active form and works by specifically blocking the angiotensin II type 1 (AT1) receptors in blood vessels. Angiotensin II is a vasoconstrictor that narrows the blood vessels, leading to high blood pressure. It also promotes the release of aldosterone, which gives rise to sodium and water retention in the kidneys. Olmecip stops these phenomena and reduces the volume of fluid in the bloodstream, allowing the blood vessels to relax and thus reducing overall blood pressure. It is taken once daily and provides 24-hour control of blood pressure levels.
Olmecip 20 mg is a prescription medicine mainly used for treating and managing high blood pressure (hypertension) in adults. It may be prescribed in some cases of heart failure or for kidney protection in people with type 2 diabetes who also suffer from high blood pressure. The active ingredient of the medicine is Olmesartan, which belongs to a group of drugs called angiotensin II receptor blockers (ARBs). This group of drugs works by blocking the effects of angiotensin II, a hormone that constricts the blood vessels and raises blood pressure. The medicine prevents this hormone from binding to its receptors, thereby causing the widening of blood vessels and ultimately leading to a decrease in blood pressure. Thus, Olmecip prevents strokes, heart attacks, and kidney problems, making it an important and effective medication in the prevention of cardiovascular disease. Cipla Ltd. manufactures this medicine. The major benefits of Olmesartan are that it works by blocking only angiotensin II receptors, without affecting other receptors in the body. This targeted approach makes the drug very effective and presents high tolerability in most patients.
Mechanism of action: When Olmecip is ingested, it is converted into its active form and works by specifically blocking the angiotensin II type 1 (AT1) receptors in blood vessels. Angiotensin II is a vasoconstrictor that narrows the blood vessels, leading to high blood pressure. It also promotes the release of aldosterone, which gives rise to sodium and water retention in the kidneys. Olmecip stops these phenomena and reduces the volume of fluid in the bloodstream, allowing the blood vessels to relax and thus reducing overall blood pressure. It is taken once daily and provides 24-hour control of blood pressure levels.
Dosage and Administration: The standard starting dose of Olmecip is typically 20 mg once daily. Sometimes it is increased to 40 mg per day as needed by the patient under the guidance of physicians. It can be taken with or without food; however, for optimal results, it is best to take the medicine at the same time each day. It is advised to swallow the medicine whole with water, and it is recommended to avoid crushing or chewing it. Consistency is very important, as blood pressure can fluctuate if doses are missed.
Olmecip works by targeting specific angiotensin II receptors involved in blood pressure regulation, which allows for precise action with fewer side effects. It is generally well-tolerated, but in some cases, it may cause side effects.
Some common side effects include dizziness, headache, and mild gastrointestinal disturbances, such as diarrhoea. The symptoms are temporary and tend to improve as the body adjusts to the medication. But sometimes some patients can experience serious side effects, which include severe drops in blood pressure, especially in people who are also taking diuretics or have low blood volume. Sometimes Olmecip affect kidney functioning in people with pre-existing kidney conditions or those taking other medications that impact kidney health. There is one extremely rare and serious side effect, a condition called sprue-like enteropathy. This causes severe chronic diarrhoea, weight loss, and intestinal inflammation, and can occur months or even years after starting the medication. High potassium levels or hyperkalemia are another issue, especially in people with kidney dysfunction or those who are also using potassium supplements or potassium-sparing diuretics.
Olmecip 20 mg is a highly effective medication for controlling high blood pressure and reducing associated health risks. However, it should be used under the guidance of a physician. Regular monitoring and consultation with a physician are essential for ensuring both the effectiveness and safety of treatment with Olmecip. With proper use, this Olmesartan formulation can play a crucial role in managing hypertension and improving long-term cardiovascular outcomes.
Login
Sign Up
Login
Sign Up